- Issuer ticker
-
EDIT
- Reported as of
-
17 Jun 2026
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
22 Jun 2026, 16:30:09 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Andrew Hirsch
Key filing fact
Andrew Hirsch filed Form 4 for Editas Medicine, Inc. (EDIT) on 22 Jun 2026.
Key facts
- This page summarizes Andrew Hirsch's Form 4 filing for Editas Medicine, Inc. (EDIT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 22 Jun 2026, 16:30.
Change
- Previous filing in this sequence was filed on 18 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reporting Owners (1)
CIK 0001586707
Primary reporting owner
Hirsch Andrew
- Relationship
-
Director
- Address
- C/O EDITAS MEDICINE, INC.,, 11 HURLEY ST., CAMBRIDGE
- Signature
- /s/ Andrew Hirsch
- Signature date
- 22 Jun 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
EDIT
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +51,700
- Change %
- Price
-
$0.000000*
- Shares after
- 51,700
- Date
- 17 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 51,700
- Exercise price
- $2.55
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Explanation of responses
1 footnote